These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

974 related items for PubMed ID: 33709339

  • 1. Efficacy and Safety of Direct Oral Anticoagulants vs Warfarin in Patients with Chronic Kidney Disease and Dialysis Patients: A Systematic Review and Meta-Analysis.
    Chen HY, Ou SH, Huang CW, Lee PT, Chou KJ, Lin PC, Su YC.
    Clin Drug Investig; 2021 Apr; 41(4):341-351. PubMed ID: 33709339
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness and Safety of Direct Oral Anticoagulants in an Asian Population with Atrial Fibrillation Undergoing Dialysis: A Population-Based Cohort Study and Meta-Analysis.
    See LC, Lee HF, Chao TF, Li PR, Liu JR, Wu LS, Chang SH, Yeh YH, Kuo CT, Chan YH, Lip GYH.
    Cardiovasc Drugs Ther; 2021 Oct; 35(5):975-986. PubMed ID: 33211254
    [Abstract] [Full Text] [Related]

  • 3. A systematic review of direct oral anticoagulant use in chronic kidney disease and dialysis patients with atrial fibrillation.
    Feldberg J, Patel P, Farrell A, Sivarajahkumar S, Cameron K, Ma J, Battistella M.
    Nephrol Dial Transplant; 2019 Feb 01; 34(2):265-277. PubMed ID: 29509922
    [Abstract] [Full Text] [Related]

  • 4. Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease.
    Kimachi M, Furukawa TA, Kimachi K, Goto Y, Fukuma S, Fukuhara S.
    Cochrane Database Syst Rev; 2017 Nov 06; 11(11):CD011373. PubMed ID: 29105079
    [Abstract] [Full Text] [Related]

  • 5. Anticoagulation in Patients with Chronic Kidney Disease.
    Elenjickal EJ, Travlos CK, Marques P, Mavrakanas TA.
    Am J Nephrol; 2024 Nov 06; 55(2):146-164. PubMed ID: 38035566
    [Abstract] [Full Text] [Related]

  • 6. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
    Almutairi AR, Zhou L, Gellad WF, Lee JK, Slack MK, Martin JR, Lo-Ciganic WH.
    Clin Ther; 2017 Jul 06; 39(7):1456-1478.e36. PubMed ID: 28668628
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of direct oral anticoagulants in patients with atrial fibrillation and chronic kidney disease.
    Bhatia HS, Bailey J, Unlu O, Hoffman K, Kim RJ.
    Pacing Clin Electrophysiol; 2019 Nov 06; 42(11):1463-1470. PubMed ID: 31599969
    [Abstract] [Full Text] [Related]

  • 8. Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population.
    Amin A, Keshishian A, Dina O, Dhamane A, Nadkarni A, Carda E, Russ C, Rosenblatt L, Mardekian J, Yuce H, Baker CL.
    J Thromb Thrombolysis; 2019 Aug 06; 48(2):240-249. PubMed ID: 30924051
    [Abstract] [Full Text] [Related]

  • 9. Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex.
    Carnicelli AP, Hong H, Connolly SJ, Eikelboom J, Giugliano RP, Morrow DA, Patel MR, Wallentin L, Alexander JH, Cecilia Bahit M, Benz AP, Bohula EA, Chao TF, Dyal L, Ezekowitz M, A A Fox K, Gencer B, Halperin JL, Hijazi Z, Hohnloser SH, Hua K, Hylek E, Toda Kato E, Kuder J, Lopes RD, Mahaffey KW, Oldgren J, Piccini JP, Ruff CT, Steffel J, Wojdyla D, Granger CB, COMBINE AF (A Collaboration Between Multiple Institutions to Better Investigate Non-Vitamin K Antagonist Oral Anticoagulant Use in Atrial Fibrillation) InvestigatorsDivision of Cardiology (A.P.C., M.R.P., J.H.A., R.D.L., J.P.P., C.B.G.), Duke University, Durham, NC..
    Circulation; 2022 Jan 25; 145(4):242-255. PubMed ID: 34985309
    [Abstract] [Full Text] [Related]

  • 10. Direct Oral Anticoagulant Use in Chronic Kidney Disease and Dialysis Patients With Venous Thromboembolism: A Systematic Review of Thrombosis and Bleeding Outcomes.
    Cheung CYS, Parikh J, Farrell A, Lefebvre M, Summa-Sorgini C, Battistella M.
    Ann Pharmacother; 2021 Jun 25; 55(6):711-722. PubMed ID: 33073581
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Oral anticoagulants for prevention of stroke in atrial fibrillation: systematic review, network meta-analysis, and cost effectiveness analysis.
    López-López JA, Sterne JAC, Thom HHZ, Higgins JPT, Hingorani AD, Okoli GN, Davies PA, Bodalia PN, Bryden PA, Welton NJ, Hollingworth W, Caldwell DM, Savović J, Dias S, Salisbury C, Eaton D, Stephens-Boal A, Sofat R.
    BMJ; 2017 Nov 28; 359():j5058. PubMed ID: 29183961
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effectiveness and Safety of Standard-Dose Nonvitamin K Antagonist Oral Anticoagulants and Warfarin Among Patients With Atrial Fibrillation With a Single Stroke Risk Factor: A Nationwide Cohort Study.
    Lip GYH, Skjøth F, Nielsen PB, Kjældgaard JN, Larsen TB.
    JAMA Cardiol; 2017 Aug 01; 2(8):872-881. PubMed ID: 28614582
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Oral anticoagulation in patients with chronic kidney disease: A systematic review and meta-analysis.
    Malhotra K, Ishfaq MF, Goyal N, Katsanos AH, Parissis J, Alexandrov AW, Alexandrov AV, Tsivgoulis G.
    Neurology; 2019 May 21; 92(21):e2421-e2431. PubMed ID: 31068485
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 49.